Skip to main content
. 2025 May 9;13:1574361. doi: 10.3389/fpubh.2025.1574361

Table 2.

Comparison of comorbidities and risk factors between anti-HEV IgG positive and negative patients.

Comorbid conditions and epidemiological characteristics of the patients HEV IgG status p value
Negative Positive
n % n %
Comorbidities Yes 64 54.2% 23 54.8% 0.953
No 54 45.8% 19 45.2%
Diabetes mellitus Yes 43 36.4% 20 47.6% 0.203
No 75 63.6% 22 52.4%
Hypertension Yes 74 62.7% 25 59.5% 0.715
No 44 37.3% 17 40.5%
COLD Yes 3 2.5% 4 9.5% 0.077
No 115 97.5% 38 90.5%
Coronary artery disease Yes 10 8.5% 5 11.9% 0.542
No 108 91.5% 37 88.1%
Heart failure Yes 14 11.9% 3 7.1% 0.563
No 104 88.1% 39 92.9%
Residential area Urban 109 92.4% 38 90.5% 0.745
Rural 9 7.6% 4 9.5%
Blood transfusion Yes 36 30.5% 8 19.0% 0.153
No 82 69.5% 34 81.0%
History of animal husbandry Yes 4 3.4% 2 4.8% 0.653
No 114 96.6% 40 95.2%
Source of drinking water Treated water 24 20.3% 8 19.0% 0.294
Natural source 36 30.5% 8 19.0%
Tap water 58 49.2% 26 61.9%
Consumption of raw meat No 118 100.0% 42 100.0% -

Categorical variables are expressed as frequency (percentage). Chis-quare test or Fisher’s exact test, p-value of significance, p < 0.05.